Adopting a wider view: factoring blood, biopsy, and urine into kidney transplant outcomes

2025/10/17 by Harry Robertson, Griffith B. Perkins · 1 voice
Medicine · #Dialysis and Renal Disease Management #Organ Donation and Transplantation #Renal Transplantation Outcomes and Treatments

paper · pdf · doi:10.1016/j.kint.2025.07.020

openalex publication_date 2025/10/17 · crossref created 2025/10/17 · openalex created_date 2025/10/18 · crossref deposited 2025/10/18 · crossref indexed 2025/10/19 · crossref issued 2025/11/01 · crossref published 2025/11/01 · crossref published-print 2025/11/01 · openalex updated_date 2026/07/28

Citations

• A randomized controlled trial of intravenous immunoglobulin vs standard of care for the treatment of chronic active antibody-mediated rejection in kidney transplant recipients
• Multi-omic factor analyses uncovered cross-compartment complexity of biological processes in kidney transplantation

Discussions

• Commentary Adopting a wider view: factoring blood, biopsy, and urine into kidney transplant outcomes Robertson & Perkins doi.org/10.1016/j.kint.2025.07.020 Original Article: doi.org/10.1016/j.kint.20 [bsky, 2 points, 0 comments]